CP-115,953 stimulates cytokine production by lymphocytes.
The cytotoxic quinolone CP-115,953 specifically exerts its inhibitory effect upon eukaryotic topoisomerase II. CP-115,953 stimulates DNA cleavage mediated by topoisomerase II with a potency approximately 600 times greater than that of ciprofloxacin, a quinolone antibacterial agent that currently is...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1995
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162563/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7726518/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.2.476 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|